ARCHIVES

Ibrutinib Demonstrates 71% ORR In Phase Ib/II CLL and SLL Study

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Three Genetics Pioneers Win Nobel Prize

October 11, 2002

NCI Board of Scientific Advisors rejects the Institute’s $89 million proteomics research plan.

March 11, 2005

Edward Harlow Named Recipient Of Bristol Award

March 29, 1991

Three Win Nobel Prize In Medicine; Irving Center Awarded $10M For Breast Cancer Research.

October 13, 2000

NCI To Offer Planning Grants for New Centers

November 9, 1990

Pancreatic Cancer Pain Reduction Concept Approved

May 23, 1986